Benzinga | Feb 25, 2021 07:58AM EST

Gossamer Bio Q4 EPS $(0.88) Misses $(0.79) Estimate

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.79) by 11.39 percent. This is a 1.12 percent increase over losses of $(0.89) per share from the same period last year.